A crucial element of regenerative treatment and drug discovery lies in the ability to multiply human stem cell collections to sufficient numbers for therapeutic applications. Traditionally, constrained cell presence posed a significant obstacle to progress in these fields. Consequently, considerable endeavor has been directed towards optimizing pro